Proteomics-based Early diagnosis using multiple markers provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests. Early diagnostic solutions BERTIS has commercialized MASTOCHECK, the worlds first proteomics-based blood test solution for early diagnosis of breast cancer, and clinical trials are being conducted on biomarkers for various cancers. Ultimately, these technologies are being used to continually expand the pipeline to allow dozens of diseases to be diagnosed with a single blood test.
Biomarker Diseases Diagnosis Blood Tests Proteomics-based early diagnosis Provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests. Advantages of proteomics-based early diagnosis: Proteomics-based early diagnosis determines the presence of disease by identifying proteins that are specifically expressed in diseases and using these as biomarkers to measure the quantitative values of the relevant proteins in blood. Proteomics analysis has been assessed as highly likely to be used as a universal primary screening method because analysis can be performed even with trace samples, such as a few drops of blood.
PC-PASS Protein Characterization Analysis Protein Characterization (Physicochemical property of proteins) structure analysis using mass spectrometry provides results that meet the requirements of the FDA, the MFDS and other regulatory authorities regarding novel therapies or biosimilars. Based on basic amino acid analysis (full sequencing), we perform post-translational modification (PTM) analysis, which is important for protein potency and stability. In this regard, we can perform test methods based on design of experiment (DOE) statistical methodology and deliver documents to be submitted to regulatory authorities. Protein identification and quantification : Structural analysis of all types of protein therapeutics, including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and enzymes - Full Length-Amino acids sequencing Peptide identification of each peak through peptide mapping (MS spectrum confirmation, MS/MS spectral analysis with 100% AA matches) - Improved N- and C-terminal sequencing of proteins Post-translational modification (PTM) : More reliable results based on design of experiment (DOE) statistical methodology to perform the experiments systematically and analyze data efficiently - Disulfide bond analysis ID Total possible lankage analysis - Deamidation identification and quantification - Phosphorylation identification and quantification , phospho-proteomic analysis - Other functional modifications Glycomics : Single protein analysis and research of protein complexes with glycosylation closely related to biological function and toxicity as well as structural stability of proteins - Glycosylation site determination - Glycan profiling - Site-specific glycan identification and quantification - Glycomics research with glycan enrichment
Real Time Voice Analyzer Smartphone App Bulk Screening Tests for COVID, Flu, and other Respiratory Diseases on Smartphones using AI Technology Quantity Available: UNLIMITED Pricing: As low as $0.50 per test Product Website: RTVoiceTest.com Business Registration Website: RTNAccount.com The Real Time Voice Analyzer (RTVA) is an advanced AI screening app for Apple and Android smartphones that utilizes voice biomarkers and AI algorithms to detect airborne respiratory viruses, including COVID-19 and its variants and even some strains of influenza and the common cold. The RTVA app is Fast, Accurate, and Non-Invasive, and free to download. For more information and a Free Trial (no credit card needed), please visit: RTVoiceTest.com We offer bulk discounts on screening tests to large companies and organizations. With pricing as low as $0.50 per test, and UNLIMITED TESTING, the RTVA is ideal for large to very large groups. For more information, please contact:
One step, rapid immunochromatographic assay for detectionof NS1Ag of all serotypes of Dengue virus in human serum orplasmaDetection of infection prior to sero - conversionDetects all serotypes (DEN-1,DEN-2,DEN-3, DEN-4)Specimen volume : 90 - 100 ul of Serum/PlasmaNo sample preparation requiredResult interpretation time: 20 minsSensitivity :> 95%. Specificity : =95%
Testing 1
Test Test Test Test Test Test
test test test test test test test test test test test test test test test test test test test test test test test test test test test
CE Certified Assay+ Covid 19 IgG / IgM Rapid Test Assay+ Covid 19 antibody rapid test is manufactured in Canada to detect specific Covid 19 IgG and IgM for the healthcare providers. Assay+ COVID-19 Rapid Test Kit is qualitative test device for SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, whole blood or finger tip blood. This device has been authorized by CE Mark and waiting for FDA approval. Sensitivity over 90 for IgM and 95-100% for IgG and 100% specifity have been proved used by our customers in large quantity and tested by multiple clinical agreement studies in the University Medical Center, Brooklyn at New York, USA , Henry Ford Hospital at Michigan, USA, we'll supply the high quality product for our customers. You can visit our web site https://bioassayplus.com, email: info@immunoassay.ca, or marketing@bioassayplus.com, or call phone 313 455 0968. New test is under the way: 1. Covid 19 antigen rapid test 2. Covid 19 protective antibody and titer rapid test ( Test antibody reaction after taking Covid 19 vaccine) 3. We also supply raw materials for diagnostic industry, please check Bioassayplus.com Package and Price for Covid 19 IgG/IgM rapid test: 25 test kits per box 100 to 2500, 1.99 USD per test, 2501 to 4999, 1.80 USD per test 5000 to 50,000, 1.75 USD per test 50,000 to 1000, 000 or more, 1.65 USD per test
CE marked Dengue virus IgG/IgM rapid test Assay+ Dengue IgG/IgM antibody rapid test is manufactured in Canada to detect specific dengue IgG and IgM for the healthcare providers. Assay+ dengue IgG/IgM Rapid Test Kit is qualitative test device for dengue virus IgM/IgG antibodies in human serum, plasma, whole blood or finger tip blood. This device has been authorized by CE Mark. Sensitivity over 90% for IgM and IgG and 100% specificity have been proved used by our customers in large quantity.
Assay+ Ebola IgG /IgM antibody rapid test is manufactured in Canada to detect specific Ebola IgG and IgM for the healthcare providers. Assay+ Ebola IgG / IgM Rapid Test Kit is qualitative test device for Ebola IgG/IgMantibodies in human serum, plasma, whole blood or finger tip blood. This device has been tested in large quantity in Ebola pandemic region. Sensitivity over 90% for IgM and IgG and 100% specificity have been proved used by our customers in large quantity.
Assay+ Zika antibody rapid test is manufactured in Canada to detect specific Zika IgG and IgM for the healthcare providers. Assay+ Zika Rapid Test Kit is qualitative test device for Zika IgM/IgG antibodies in human serum, plasma, whole blood or finger tip blood. This device has been used by our end customers with large quantitiy. Sensitivity over 65% for IgM and 85% for IgG and 100% specificity have been proved used by our customers in large quantity.
CE Certified Assay+ Covid 19 IgG / IgM Rapid Test Assay+ Covid 19 antibody rapid test is manufactured in Canada to detect specific Covid 19 IgG and IgM for the healthcare providers. Assay+ COVID-19 Rapid Test Kit is qualitative test device for SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, whole blood or finger tip blood. This device has been authorized by CE Mark and waiting for FDA approval. Sensitivity over 90% for IgM and 100% for IgG and 100% specifity have been proved used by our customers in large quantity and tested by multiple clinical agreement studies in the University Medical Center, Brooklyn at New York, USA , Henry Ford Hospital at Michigan, USA, we'll supply the high quality product for our customers.
Assay+ dengue NS1 antigen rapid test is manufactured in Canada to detect dengue antigen for the healthcare providers. Assay+ dengue NS1 Rapid Test Kit is qualitative test device for dengue NS1 infection from human serum or plasma.. This device has been used by our end customers with large quantity. Sensitivity over 80% and 100% specificity have been proved used by our customers in large quantity.
Assay+ Coivd 19 Neutralizing antibody rapid test is manufactured in Canada to detect specific Covid 19 neutralizing IgG for the healthcare providers. Assay+ neutralizing Covid 19 antibody Rapid Test Kit is qualitative test device, but it can monitor the neutralizing antibody titer. This test can detect the neutralizing antibody from human serum, plasma, whole blood or finger tip blood. This device has been used by our end customers with good feedback.
Accu check active test strip and performa strips.
Rapid test kits.
Covid 19 rapid test kit.
Panodyne covid 19 antibody rapid test kit.
Rapid antigen test kits.
